Whilst there are numerous studies that investigate the role of CD4+ Tregs in alleviating GVHD, future studies should seek to determine the efficacy of other regulatory cells such as KIR+CD8+ T cells and MDSCs. This evidence concerns the gene CD8A and graft versus host disease.